---
qid: ing_82d501c99b__fp__local
question: How do you evaluate a manipulation policy when every trial costs robot time
  and every failure has physical consequences?
topic: AI
model: openai/gpt-oss-20b
provider: lmstudio
input_tokens: 179
output_tokens: 435
total_tokens: 614
web_searches: 0
cost_usd: 0.0
generated_at: '2026-09-05T20:43:26-05:00'
sources: []
---

When a robot must learn *how* to manipulate safely, each episode is an expensive sample: the hardware wears out, and a bad action can damage objects or the robot itself.  
The core problem is therefore **exploration under cost‑sensitive risk**—we want a policy that maximises expected return while minimising physical loss.

1. **Formulate as constrained Markov decision process (CMDP)**  
   *Reward* \(r_t\) captures task success;  
   *Cost* \(c_t\) quantifies wear or damage (e.g., torque spikes, collisions).  
   The objective is \(\max_{\pi}\mathbb{E}[R]\) subject to \(\mathbb{E}[C]\leq \bar{C}\).

2. **Dual‑space optimisation**  
   Introduce Lagrange multiplier \(\lambda\) and optimise the *Lagrangian* \(L = \mathbb{E}[R] - \lambda (\mathbb{E}[C]-\bar{C})\).  
   This turns a hard constraint into a scalar penalty, allowing standard policy‑gradient or actor–critic methods to learn safely.

3. **Information‑theoretic safety**  
   Treat each trial as an *information acquisition* step: the variance of the cost estimator shrinks with data.  
   Use Bayesian optimisation to select actions that maximise expected improvement in the posterior over \(\lambda\), effectively balancing exploration and risk.

4. **Non‑obvious insight** – *cost‑sensitive curiosity*.  
   Instead of purely random exploration, bias intrinsic motivation towards states where the model is uncertain about cost but confident about reward.  
   This focuses trials on “borderline” safety zones, yielding the most informative data per unit wear.

By casting manipulation as a constrained optimisation problem and coupling it with Bayesian uncertainty‑aware exploration, one can rigorously evaluate policies while keeping physical risk—and thus trial costs—under tight control.

_Written by openai/gpt-oss-20b running locally. Machine-generated, not reviewed._
